REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis Risk
Javeed A. Shah(University of Washington), Thomas R. Hawn(University of Washington), Mark Hatherill(South African Tuberculosis Vaccine Initiative), Phan Vuong Khac Thai(Pham Ngoc Thach Hospital), Guy Thwaites(Oxford University Clinical Research Unit), Carlo A. Hernandez(University of Washington), Willem A. Hanekom(Africa Health Research Institute), Alex J. Warr(University of Washington), Nguyễn Thụy Thương Thương(University of Oxford), Andrew D. Graustein(University of Washington), Katherine A. Fitzgerald(University of Massachusetts Chan Medical School), Sarah J. Dunstan(The University of Melbourne), Thomas J. Scriba(South African Tuberculosis Vaccine Initiative), Munyaradzi Musvosvi(South African Tuberculosis Vaccine Initiative), Christopher M. Sassetti(University of Massachusetts Chan Medical School), Maxine Caws(Liverpool School of Tropical Medicine), Aparajita Saha(University of Washington), Anele Gela(South African Tuberculosis Vaccine Initiative), Chiea Chuen Khor(Agency for Science, Technology and Research), Xuling Chang(The University of Melbourne), Zheng Li(Central South University), Madison A. Jones(University of Washington), Felicia K. Nguyen(University of Washington), Nguyen Duc Bang(Pham Ngoc Thach Hospital), Martin L. Hibberd(London School of Hygiene & Tropical Medicine)
Cited by 9
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
|Nature Immunology|2010|3k